NCT06707103View on ClinicalTrials.gov

Tissue Repair Gel in Venous Leg Ulcers in AU/US

PHASE3RecruitingINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
Venous Leg UlcerVenous UlcerVenous Stasis UlcerVenous StasisWound HealWoundVenous Insufficiency of LegNon-healing Wound
Interventions
DRUG

TR987 0.1% gel + Standard of Care

6mg topical gel for application plus Standard of Care (wound cleansing/dressings and compression bandaging)

OTHER

Standard of care

Standard of Care (wound cleansing/dressings and compression bandaging)

Trial Locations (12)

2050

NOT_YET_RECRUITING

Clincial Research Site 62, Camperdown

2065

NOT_YET_RECRUITING

Clincial Research Site 85, Sydney

2217

NOT_YET_RECRUITING

Clinical Research Site 84, Kogarah

2800

NOT_YET_RECRUITING

Clincial Research Site 78, Orange

3079

RECRUITING

Clincial Research Site 60, Ivanhoe

3550

NOT_YET_RECRUITING

Clincial Research Site 74, Bendigo

3630

RECRUITING

Clincial Research Site 65, Shepparton

6009

NOT_YET_RECRUITING

Clincial Research Site 75, Nedlands

11042

NOT_YET_RECRUITING

Clincial Research Site 82, Lake Success

32256

RECRUITING

Clincial Research Site 92, Jacksonville

48038

RECRUITING

Clincial Research Site 77, Clinton Twp

76104

RECRUITING

Clinical Research Site 76, Fort Worth

All Listed Sponsors
lead

TR Therapeutics

INDUSTRY